A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282

Clinical trial NCT06858865 · COMPLETED

Trial details

NCT number: NCT06858865
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Hypercholesterolaemia

Start date: 2025-07-12
Primary completion: 2025-08-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.